“…The AMPs are considered as a primitive class of defense mechanisms in a variety of eukaryotic and prokaryotic organisms. , A plethora of these gene-encoded peptides is immediately mobilized followed by the microbial infections. The AMPs have common properties, including the molecular mass of about 0.3–5 kDa, overall net positive charge, hydrophobic nature, and membrane-lytic mode of action. , These sequences may be categorized in terms of their lengths, primary structures (their distinctive amino acid composite), and the presence or absence of disulfide bridges . Despite these effects, the AMPs suffer inherent drawbacks, such as patent monopoly for economic concerns, high costs for synthesis and bioscreening, limited activity due to the salt, serum, and pH sensitivity, proteolytic stability, unknown systemic and local toxicities, and allergic reactions. , Nevertheless, the design and development of new synthetic AMPs through the manipulation of the peptide structure is an efficient strategy aiming to prevent and treat systemic and topical infections caused by the bacterial superbugs …”